Fredun Pharmaceuticals Limited (BOM:539730)
India
· Delayed Price · Currency is INR 1,577.60
+43.45 (2.83%)
At close: Mar 9, 2026
Fredun Pharmaceuticals Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Net Income | - | 197.39 | 156.23 | 108.07 | 63.35 | 20.15 | Upgrade
|
| Depreciation & Amortization | - | 49.14 | 37.42 | 27.65 | 21.33 | 19.82 | Upgrade
|
| Other Amortization | - | 1.26 | 0.54 | 0.44 | 0.24 | 0.22 | Upgrade
|
| Other Operating Activities | - | 303.08 | 187.99 | 155.43 | 79 | 66.47 | Upgrade
|
| Change in Accounts Receivable | - | -1,123 | -302.89 | 557.13 | -491.98 | -21.01 | Upgrade
|
| Change in Inventory | - | -648.91 | -248.74 | -1,037 | 211.14 | -171.13 | Upgrade
|
| Change in Accounts Payable | - | 818.41 | 36.04 | 107.26 | -113.44 | 137.37 | Upgrade
|
| Change in Income Taxes | - | 15.81 | 12.45 | -27.91 | -5.45 | -21.99 | Upgrade
|
| Change in Other Net Operating Assets | - | 95.92 | 116.57 | -35.53 | 212 | -28.2 | Upgrade
|
| Operating Cash Flow | - | -290.63 | -4.39 | -144.09 | -23.8 | 1.7 | Upgrade
|
| Capital Expenditures | - | -61.06 | -76.39 | -94.95 | -42.86 | -13.88 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 1.12 | - | 0.9 | 1.43 | - | Upgrade
|
| Investment in Securities | - | -3.6 | - | - | - | - | Upgrade
|
| Investing Cash Flow | - | -63.54 | -76.39 | -94.05 | -41.43 | -13.88 | Upgrade
|
| Short-Term Debt Issued | - | 640.82 | 216.05 | 271.78 | 1.97 | - | Upgrade
|
| Long-Term Debt Issued | - | - | - | 68.89 | 129.29 | 176.15 | Upgrade
|
| Total Debt Issued | - | 640.82 | 216.05 | 340.67 | 131.25 | 176.15 | Upgrade
|
| Short-Term Debt Repaid | - | - | - | - | - | -128.71 | Upgrade
|
| Long-Term Debt Repaid | - | -24.45 | -26.42 | - | - | - | Upgrade
|
| Total Debt Repaid | - | -24.45 | -26.42 | - | - | -128.71 | Upgrade
|
| Net Debt Issued (Repaid) | - | 616.37 | 189.63 | 340.67 | 131.25 | 47.44 | Upgrade
|
| Issuance of Common Stock | - | 0.33 | - | - | - | - | Upgrade
|
| Other Financing Activities | - | -225.53 | -129.7 | -88.9 | -56.58 | -54.57 | Upgrade
|
| Financing Cash Flow | - | 391.16 | 59.93 | 251.77 | 74.67 | -7.13 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | 0 | -0 | -0 | - | 0 | Upgrade
|
| Net Cash Flow | - | 36.99 | -20.85 | 13.63 | 9.44 | -19.31 | Upgrade
|
| Free Cash Flow | - | -351.69 | -80.78 | -239.03 | -66.66 | -12.18 | Upgrade
|
| Free Cash Flow Margin | - | -7.75% | -2.32% | -8.70% | -2.97% | -0.91% | Upgrade
|
| Free Cash Flow Per Share | - | -75.76 | -17.40 | -53.38 | -16.05 | -3.05 | Upgrade
|
| Cash Interest Paid | - | 223.77 | 136.5 | 92.82 | 46.69 | 41.62 | Upgrade
|
| Levered Free Cash Flow | - | -551.15 | -269.38 | -445.24 | -337.49 | -79.01 | Upgrade
|
| Unlevered Free Cash Flow | - | -423.5 | -191.14 | -397.98 | -310.05 | -55.02 | Upgrade
|
| Change in Working Capital | - | -841.49 | -386.57 | -435.68 | -187.73 | -104.95 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.